Experimental universal flu vaccine with an mRNA-based design enters trial

The phase I trial will test safety and efficacy in a small number of people.

https://arstechnica.com/health/2023/05/experimental-universal-flu-vaccine-with-an-mrna-based-design-enters-trial/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social